NCT05011123View on ClinicalTrials.gov

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

May 23, 2022

Study Completion Date

April 23, 2027

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Yellow fever vaccine (produced on serum-free Vero cells)

Powder and diluent for suspension for injection - Subcutaneous

BIOLOGICAL

Yellow fever vaccine

Powder and diluent for suspension for injection - Subcutaneous

Trial Locations (23)

10117

Investigational Site Number : 2760004, Berlin

10330

Investigational Site Number : 7640001, Bangkok

11000

Investigational Site Number : 7640003, Nonthaburi

18057

Investigational Site Number : 2760003, Rostock

20359

Investigational Site Number : 2760001, Hamburg

20520

Investigational Site Number : 2460003, Turku

28046

Investigational Site Number : 7240002, Madrid

30029

Investigational Site Number : 2500007, Nîmes

33100

Investigational Site Number : 2460002, Tampere

34295

Investigational Site Number : 2500006, Montpellier

44093

Investigational Site Number : 2500001, Nantes

69004

Investigational Site Number : 2500008, Lyon

69495

Investigational Site Number : 2500004, Pierre-Bénite

75014

Investigational Site Number : 2500009, Paris

80802

Investigational Site Number : 2760002, München

119074

Investigational Site Number : 7020002, Singapore

169608

Investigational Site Number : 7020003, Singapore

00290

Investigational Site Number : 2460001, Helsinki

Unknown

Investigational Site Number : 7020001, Singapore

Investigational Site Number : 7640002, Bangkok

08035

Investigational Site Number : 7240004, Barcelona

08907

Investigational Site Number : 7240003, L'Hospitalet de Llobregat

08036

Investigational Site Number : 7240001, Barcelona

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY